iGEM and Gene Drives: A Case Study for Governance

Health Secur. 2022 Jan-Feb;20(1):26-34. doi: 10.1089/hs.2021.0157. Epub 2022 Jan 11.

Abstract

Gene drives have already challenged governance systems. In this case study, we explore the International Genetically Engineered Machine (iGEM) competition's experiences in gene drive-related research and lessons in developing, revising, and implementing a governance system. iGEM's experiences and lessons are distilled into 6 key insights for future gene drive policy development in the United States: (1) gene drives deserve special attention because of their potential for widescale impact and remaining uncertainty about how to evaluate intergenerational and transboundary risks; (2) an adaptive risk management approach is logical for gene drives because of the rapidly changing technical environment; (3) review by individual technical experts is limited and may fail to incorporate other forms of expertise and, therefore, must be complemented with a range of alternative governance methods; (4) current laboratory biosafety and biosecurity review processes may not capture gene drive research or its components in practice even if they are covered theoretically; (5) risk management for research and development must incorporate discussions of values and broader implications of the work; and (6) a regular technology horizon scanning capacity is needed for the early identification of advances that could pose governance system challenges.

Keywords: Adaptive governance; Adaptive risk management; Gene drives; Governance; Risk management; iGEM.

MeSH terms

  • Gene Drive Technology*
  • Genetic Engineering
  • Humans
  • Risk Assessment
  • Risk Management
  • Uncertainty
  • United States